STA Signs Supply Agreement with Tesaro

STA Pharmaceutical Co., Ltd., a WuXi AppTec subsidiary and an open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, announces it signed a supply agreement with the oncology-focused biopharmaceutical company, Tesaro, Inc. for certain starting...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical Processing
Main Author AppTec, WuXi
Format Trade Publication Article
LanguageEnglish
Published Rockaway Advantage Business Media 25.07.2017
Subjects
Agreements
Manufacturing
Open access
Ovarian cancer
Pharmaceutical industry
United States > US
China
Online AccessGet full text

Cover

More Information
Summary:STA Pharmaceutical Co., Ltd., a WuXi AppTec subsidiary and an open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, announces it signed a supply agreement with the oncology-focused biopharmaceutical company, Tesaro, Inc. for certain starting and intermediate materials for Zejula (niraparib). Zejula is the only PARP inhibitor...
ISSN:1049-9156